Showing results (511-520 of 566) with videos related to
Sort By:
Pageof 57
Cancer Research|May 1, 1984
Effect of very high-dose thymidine infusions on leukemia and lymphoma patientsM S Blumenreich, T M Woodcock, M Andreeff, et al.Blood|March 21, 1998
Differential induction of apoptosis by fludarabine monophosphate in leukemic B and normal T cells in chronic lymphocytic leukemiaU Consoli, I El-Tounsi, A Sandoval, et al.Leukemia|June 11, 2011
Low expression of PP2A regulatory subunit B55α is associated with T308 phosphorylation of AKT and shorter complete remission duration in acute myeloid leukemia patientsP P Ruvolo, Y H Qui, K R Coombes, et al.Leukemia|September 13, 2003
Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemiaB Z Carter, M Milella, T Tsao, et al.Science (New York, N.Y.)|October 26, 1990
Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridizationD C Tkachuk, C A Westbrook, M Andreeff, et al.Cancer Research|September 1, 1992
Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemiaS M Kornblau, H J Xu, A del Giglio, et al.Leukemia & Lymphoma|October 1, 1995
Quantitative expression of proliferating cell nuclear antigen by western blot (PCNAWB) in peripheral blasts correlates with remission induction in patients with acute myelogenous leukemiaA Del Giglio, J Drach, S M Kornblau, et al.Cell Death and Differentiation|April 14, 1999
Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatmentT Kobayashi, S Ruan, J R Jabbur, et al.Blood|October 27, 1998
Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemiaZ Estrov, P F Thall, M Talpaz, et al.Blood|November 15, 1992
Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agentM Andreeff, R Stone, J Michaeli, et al.Pageof 57